Oppenheimer & Co’s Cano Health, Inc. CANO Stock Holding History

Oppenheimer & Co’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-230	Closed	-$291K	–	1596
2021 Q3	$291K	Buy	+230	New	+$279K	0.01%	1242

Other funds holding CANO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Oppenheimer & Co's CANO Position: Q4 2021 in Review

Oppenheimer & Co sold out of Cano Health, Inc. (CANO) in Q4 2021, closing a stake of 230 shares — an estimated $291K sold.

Oppenheimer & Co first reported a position in CANO in Q3 2021 and held it in 1 quarter. The position peaked at $291K in Q3 2021. 130 funds tracked by Wall St. Rank hold CANO as of Q4 2021.

Oppenheimer & Co reported no remaining Cano Health, Inc. position as of Q4 2021 after selling out during the quarter.
Oppenheimer & Co sold 230 Cano Health, Inc. shares in Q4 2021, an estimated $291K.
Oppenheimer & Co first reported a position in Cano Health, Inc. in Q3 2021 and held it in 1 quarter.
Oppenheimer & Co's Cano Health, Inc. position peaked at $291K in Q3 2021.
130 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2021.

Based on Oppenheimer & Co's 13F filing for Q4 2021, filed 2 Feb 2022.